A YAP-related signaling pathway could be proposed as part of the inflammatory cascade to develop new anti-inflammatory or anti-viral drugs that affect the upstream kinase activity of YAP, including MST1/2 and LATS1/2, which would be beneficial for the treatment of cancer and inflammatory diseases. Here, YAP1 is linked to cancer.